| Ticker Details |
|
Whitehawk Therapeutics, Inc
|
| IPO Date: |
February 12, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$269.65M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.26 | 3.51%
|
| Avg Daily Range (30 D): |
$0.14 | 3.24%
|
| Avg Daily Range (90 D): |
$0.16 | 3.85%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.26M |
| Avg Daily Volume (30 D): |
.38M |
| Avg Daily Volume (90 D): |
.38M |
| Trade Size |
| Avg Trade Size (Sh.): |
126 |
| Avg Trade Size (Sh.) (30 D): |
91 |
| Avg Trade Size (Sh.) (90 D): |
99 |
| Institutional Trades |
| Total Institutional Trades: |
84 |
| Avg Institutional Trade: |
$1.82M |
| Avg Institutional Trade (30 D): |
$.62M |
| Avg Institutional Trade (90 D): |
$2.55M |
| Avg Institutional Trade Volume: |
.22M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.56M |
| Avg Closing Trade (30 D): |
$.62M |
| Avg Closing Trade (90 D): |
$4.48M |
| Avg Closing Volume: |
514.1K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.2
|
$-.32
|
$-.37
|
|
Diluted EPS
|
$-.2
|
$-.32
|
$-.37
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
$M
|
|
Net Income / Loss
|
$-16.64M
|
$-22.19M
|
$-23.25M
|
|
Operating Income / Loss
|
$-18.11M
|
$-23.52M
|
$-24.89M
|
|
Cost of Revenue
|
$M
|
$M
|
$M
|
|
Net Cash Flow
|
$47.67M
|
$M
|
$-.36M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Aug 27, 2021
|
1:15
|
|
Dec 18, 2007
|
4.50:1
|
|
Aug 31, 2005
|
5:4
|
|
|
|
